Trials / Completed

CompletedNCT00727129

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Placebo-Controlled, Randomized, Double-Blind, Multicenter Study, to Demonstrate the Efficacy of 12 Weeks of Treatment With USL-221 on Moderate to Severe Vasomotor Symptoms and Vulvar/Vaginal Atrophy in Postmenopausal Patients

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 495 (actual)

Sponsor: Upsher-Smith Laboratories · Industry
Sex: Female
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.

Conditions

Postmenopausal Symptoms

Interventions

Type	Name	Description
DRUG	Divigel

Timeline

Start date: 2004-07-01
Completion: 2005-08-01
First posted: 2008-08-01
Last updated: 2008-09-26

Source: ClinicalTrials.gov record NCT00727129. Inclusion in this directory is not an endorsement.